Significantly elevated serum human epididymis protein-4 in chronic kidney disease patients without ovarian cancer: A large-scale retrospective study.

Published in: Journal of clinical laboratory analysis (2023)

HE-4 can be used as an alternative biomarker for diagnosing CKD as it is less affected by several preanalytical factors. Nevertheless, in clinical practice, elevated HE-4 requires taking both CKD and ovarian cancer into consideration.

Keyphrases

chronic kidney disease
end stage renal disease
clinical practice
ejection fraction
endothelial cells
newly diagnosed
induced pluripotent stem cells
amino acid
protein protein